Atreides Management LP bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 38,876 shares of the semiconductor company’s stock, valued at approximately $19,181,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Brighton Jones LLC boosted its position in Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock valued at $326,000 after purchasing an additional 79 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock valued at $1,291,000 after purchasing an additional 395 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Synopsys by 17.1% during the 2nd quarter. PNC Financial Services Group Inc. now owns 32,006 shares of the semiconductor company’s stock worth $16,409,000 after purchasing an additional 4,670 shares during the period. Finally, Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in shares of Synopsys by 47.8% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 27,170 shares of the semiconductor company’s stock worth $13,925,000 after buying an additional 8,782 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Trading Down 1.5%
Shares of Synopsys stock opened at $412.63 on Friday. The stock has a market capitalization of $79.04 billion, a P/E ratio of 64.07, a P/E/G ratio of 3.36 and a beta of 1.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The stock’s 50-day simple moving average is $461.93 and its 200 day simple moving average is $463.65.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 over the last 90 days. 0.56% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
SNPS has been the subject of several research reports. Citigroup assumed coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price target for the company. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Needham & Company LLC reiterated a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Morgan Stanley reissued an “equal weight” rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Finally, The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Synopsys currently has an average rating of “Hold” and a consensus target price of $531.00.
View Our Latest Research Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
